# Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/disease-activity-guided-dose-reduction-and-withdrawal-of-adalimumab-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Noortje van Herwaarden,Aatke van der Maas,M.J.M. Minten,F.H.J. van den Hoogen,Wietske Kievit,Ronald van Vollenhoven,J. W. J. Bijlsma,Bart J. F. van den Bemt,Alfons A den Broeder |
| Citations | 182 |
| DOI | 10.1136/bmj.h1389 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.bmj.com/content/bmj/350/bmj.h1389.full.pdf |
| OpenAlex ID | https://openalex.org/W2019159305 |
| PMID | 25858265 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Bart J. F. van den Bemt](https://scholariq.org/researchers/bart-j-f-van-den-bemt/)

## Paper journal

- [BMJ](https://scholariq.org/journals/bmj-2/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.